CNBSS 612 hormone IWHS 1010 therapy; oral NYUWHS 127 contraceptive NHS 220+648 use; use of 61 nonsteroidal SMC 714 WHS 201 Incidence, rectal vs <10 0.87(0.68-1.09) ≥25 drugs; cancer g/day Ptrend:0.27 multivitamin (2031 cases) use; smoking habits; alcohol; dietary intake of folate, red meat, total milk, and total energy OVS, Sanjoaquin, Age, sex, Prospective 63/ Incidence, 2004 0.82 (0.43-1.56) alcohol Cohort, 10 998 FFQ colorectal Q 3 vs Q 1 COL01182 Ptrend:0.424 consumption, Age: 18-89 17 years cancer, UK smoking habits M/W Norwegian 83/ Incidence, colon vs 0.82 (0.46-1.46) ≥17.9 ≤13.5 national health 50 535 cancer, men g/day Ptrend:.6 screening 11.4 years Age, attained service Gaard, 1996 age, BMI, Mid-points of study(NNHS), Enrolment by COL00008 FFQ energy intake, exposure Prospective volunteers Norway height, smoking categories vs 2.10 (0.90-4.87) Cohort, ≥11.3 ≤8.5 59/ Women status g/day Ptrend:.12 Age: 20-53 years, M/W
CNBSS IWHS NYUWHS NHS SMC WHS 612 1010 127 220+648 61 714 201 hormone therapy; oral contraceptive use; use of nonsteroidal drugs; multivitamin use; smoking habits; alcohol; dietary intake of folate, red meat, total milk, and total energy Incidence, rectal cancer (2031 cases) ≥25 vs <10 g/day 0.87(0.68-1.09) Ptrend:0.27 Sanjoaquin, 2004 COL01182 UK OVS, Prospective Cohort, Age: 18-89 M/W 63/ 10 998 17 years FFQ Incidence, colorectal cancer, Q 3 vs Q 1 0.82 (0.43-1.56) Ptrend:0.424 Age, sex, alcohol consumption, smoking habits Gaard, 1996 COL00008 Norway Norwegian national health screening service study(NNHS), Prospective Cohort, Age: 20-53 years, M/W 83/ 50 535 11.4 years Enrolment by volunteers FFQ Incidence, colon cancer, men ≥17.9 vs ≤13.5 g/day 0.82 (0.46-1.46) Ptrend:.6 Age, attained age, BMI, energy intake, height, smoking status Mid-points of exposure categories 59/ Women ≥11.3 vs ≤8.5 g/day 2.10 (0.90-4.87) Ptrend:.12
CUP_colorectal_SLR_2016_RO.docx